Learn more about NYSCF’s latest announcements, statements and research breakthroughs.
Five new NYSCF – Robertson Investigators join the prestigious community of early career scientists making the transition from post-doctoral research to their own labs. The three...
At the 10th Annual NYSCF Conference on Translational Stem Cell Research NYSCF will bring together world leaders in biotechnology, regenerative medicine, precision medicine, and pharmaceuticals to...
NYSCF and CBR Systems, Inc. DBA Cord Blood Registry (CBR) are collaborating to customize the creation of high-quality stem cell lines from umbilical cord blood tissue....
NYSCF announces a new partnership with Q-State Biosciences (Q-State) to generate high quality stem cells from patient blood cells. The collaboration will mark the first time...
NYSCF is committed to looking for novel ways to accelerate cures to the major diseases of our time through stem cell research. As an international organization...
NYSCF designed and has built a revolutionary, high-throughput robotic platform that automates and standardizes the process of transforming patient samples into stem cells. This one-of-a-kind system...
NYSCF’s Initiative on Women in Science and Engineering, or IWISE, brings together leading women and men in science, engineering and medicine to address gender equality in these...
For the first time, NYSCF scientists generated induced pluripotent stem (iPS) cells lines from skin samples of patients with primary progressive multiple sclerosis and further, they...
The NYSCF Research Institute is partnering with the Stanley Center at the Broad Institute of MIT and Harvard to develop a stem cell resource to study...
NYSCF and the Charcot-Marie-Tooth Association (CMTA), a patient-led disease foundation with a mission to advance research on genetic neuropathies leading to the development of new therapies,...
NYSCF and the Beyond Batten Disease Foundation (BBDF) were selected as a national innovator by the Milken Institute and presented their unique multistakeholder collaboration to find...
NYSCF scientists, in collaboration with others, compared stem cells created using two different methods: induced pluripotent stem (iPS) cells and stem cells created by somatic cell nuclear...
NYSCF scientists, in collaboration with others, successfully created a human cell model of sporadic Parkinson’s disease in a dish. The scientists had the unique opportunity to study...
The NYSCF Research Institute, through the launch of its repository in 2015, will provide the largest-ever number of stem cell lines available to the scientific research...
The 2014 NYSCF – Robertson Investigators were announced at NYSCF’s Ninth Annual Gala and Science Fair, held at Jazz at Lincoln Center in Manhattan. Each Investigator will...
NYSCF announced that Dr. Marius Wernig, of Stanford University, is the recipient of the NYSCF – Robertson Stem Cell Prize. Dr. Wernig and his team discovered...
NYSCF and Beyond Batten Disease Foundation (BBDF) are partnering to develop stem cell resources to investigate and explore new treatments and, ultimately, find a cure for juvenile...
Recognizing the enormous research potential of shared iPS cell lines, the NYSCF Research Institute and eagle-i Network are partnering to make NYSCF iPS cell lines and related...
A team of scientists led by the NYSCF Research Institute’s Dr. Dieter Egli report the first ever patient-specific, diploid (i.e. with two sets of chromosomes, the...
ALS research that NYSCF has supported for 8 years is now progressing to clinical trials for patients with this devastating disease. NYSCF began supporting Dr. Kevin...
NYSCF scientists, in collaboration with scientists from the Icahn School of Medicine at Mount Sinai, successfully created and used a stem cell model of familial Alzheimer’s...
NYSCF scientists, in collaboration with scientists from Columbia University Medical Center, successfully generated induced pluripotent stem cells and, subsequently, neurons from non-cryoprotected biobanked brain tissue of...
This exciting new collaboration combines NYSCF's stem cell expertise with Personalgenomes.org's detalied genetic and medical data to create a new and powerful tool to research disease...
NYSCF announced an exciting new collaboration with the National Institutes of Health Undiagnosed Disease Program (UDP) that will lead to new strategies to find cures and...
NYSCF scientists published a paper today in the journal Diabetes on a breakthrough in diabetes research that could lead to new therapeutic approaches for patients with a...
